News

BNN Bloomberg: An Interview with Dr. Gilly Regev of SaNOtize

By Mark Roeder on Nov 13, 2021 0 Comment

U.K. clinical trials for Vancouver’s SaNOtize have confirmed that its nasal spray reduced SARS-CoV-2 log viral load by more than 95 per cent in infected participants within 24 hours of treatment, and by more than 99 per cent in 72 hours. While the product is set to sell over the counter in Israel and New Zealand pharmacies, Dr. Gilly Regev says Health Canada sees their product as a drug and not a medical device, hindering the ability for SaNOtize to be available to the Canadian market sooner rather than later.

Best Seller

Special Offer! 5-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

BNN Bloomberg: An Interview with Dr. Gilly Regev of SaNOtize

Best Seller

Special Offer! 5-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

2-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

3-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

4-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

6-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

10-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

12-PACK Enovid SaNOtize Nitric Oxide Nasal Spray (NONS)

9-PACK SaNOtize NONS - Enovid Nitric Oxide Nasal Spray